ArticleScience and engineering ethics2019
Medicines Information and the Regulation of the Promotion of Pharmaceuticals.
Article in Science and engineering ethics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pharmaceutical policies: effects of policies regulating drug marketing.The Cochrane database of systematic reviews · 2023Pooled it
- Narrative over numbers: How testimonial medicine erodes safe practice.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2026Article
- The effect of market size on pharmaceutical innovation: matching estimates to policy questions.Health affairs scholar · 2026Article
- Written drug promotion from pharmaceutical companies to general practitioners: adherence to regulations over two decades.European journal of clinical pharmacology · 2025Article
- Assessing the effects of online educational intervention on pharmaceutical promotions: a pre-post study among medical and pharmacy students in Pakistan.Frontiers in pharmacology · 2025Article
- Evaluation of Drug and Herbal Medicinal Promotions on Social Media During the COVID-19 Pandemic in Relation to World Health Organization Ethical Criteria and South African Health Products Regulatory Authority Guidelines in South Africa: Cross-Sectional Content Analysis.Online journal of public health informatics · 2024Article
- Evaluation of prescriptions from tertiary care hospitals across India for deviations from treatment guidelines & their potential consequences.The Indian journal of medical research · 2024Observational
- Pharmaceutical Drug Promotion and Rational Drug Use: Assessment of Healthcare Workers Perspective.Integrated pharmacy research & practice · 2024Article
- Complexity of Data Displays in Prescription Drug Advertisements for Healthcare Providers.Therapeutic innovation & regulatory science · 2023Article
- Internet Use for Obtaining Medicine Information: Cross-sectional Survey.JMIR formative research · 2023Article
- Changes in Japanese physicians' relationships with the pharmaceutical industry between 2008 and 2021: A national survey.PloS one · 2023Article
- Marketing of medicines in primary care: An analysis of direct marketing mailings and advertisements.PloS one · 2023Article
- The effect of pharmaceutical companies' marketing mix strategies on physicians prescribing practices in Jordan: a cross-sectional study.BMC health services research · 2022Article
- Disparities in industry funding among Colorectal Surgeons: a cross-sectional study.Surgical endoscopy · 2022Article
- Trends in characteristics of the recipients of new prescription stimulants between years 2010 and 2020 in the United States: An observational cohort study.EClinicalMedicine · 2022Article
- Knowledge and Practice of Antibiotic Management and Prudent Prescribing among Polish Medical Doctors.International journal of environmental research and public health · 2022Article
- An investigation into the pharmaceutical advertising in Iranian medical journals.Journal of pharmaceutical policy and practice · 2022Article
- Pharmaceutical Sales Representatives in the United States and China: The Need for Professional Public Space.Health care analysis : HCA : journal of health philosophy and policy · 2022Article
- The attitude and acceptability towards medical promotional tools and their influence on physicians' prescribing practices in Jordan and Iraq: a cross-sectional study.BMC health services research · 2022Article
- An overview of Fintech applications to solve the puzzle of health care funding: state-of-the-art in medical crowdfunding.Financial innovation · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Many factors contribute to the inappropriate use of medicines, including not only a lack of information but also inaccurate and misleading promotional information. This review examines how the promotion of pharmaceuticals directly affects the prescribing and use of medicines. We define promotion broadly as all actions taken directly by pharmaceutical companies with the aim of enhancing product sales. We look in greater detail at promotion techniques aimed at prescribers, such as sales representatives, pharmaceutical advertisements in medical journals and use of key opinion leaders, along with the quality of information provided and the effects thereof. We also discuss promotion to the public, through direct-to-consumer advertising, and its effects. Finally, we consider initiatives to regulate promotion that come from industry, government and nongovernmental organizations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.